"Plans should really be
talking with their PBMs and determining what types of changes they might be
making for 2022. What formulary changes will they need to make? Does this mean
they're going to renegotiate rebate amounts, and does that impact the rebate guarantees
they have in place?"
— Katie Holcomb, principal and consulting actuary with Milliman,
spoke with AIS's RADAR on
Medicare Advantage about how MA-PD sponsors should prepare for the
2022 bidding cycle in light of the Trump administration's latest rule changes.
Subscribers may read the RADAR on Medicare Advantage article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.
No comments:
Post a Comment